Bioworld Financial Watch articles from March 2002

Bioworld Financial Watch archives from March 2002

Investor scrutiny, bad news help keep IPO window closed.
March 4, 2002... Private biotech companies planning to go public played the waiting game in 2001. They waited for the right moment, when the window would fly up and investors would flock to their brokers. But just as that window started to inch open late last...

10 biggest U.S. gainers & losers for the week.
March 4, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) ImClone Sys 73.76 ImClone Sys 11.58 LION bioscience 26.87 Gilead Sciences 7.26 Incara Pharma 23.81 Sepracor 5.65 CIMA...

Biotech mergers and acquistions: Nov. 20, 2001 - Feb. 27, 2002.
March 4, 2002... Biotech Mergers And Acquisitions: Nov. 20, 2001 - Feb. 27, 2002 (#) I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired Or Merged With Announced...

BioWorld stock report for public biotechnology companies.
March 4, 2002... BioWorld Stock Report For Public Biotechnology Companies % Change Close Close Company Symbol 2/22 3/1 WK YTD ...

PharmaStem fires broad volley in Cord-Blood War.
March 11, 2002... The phrase "stem cells" can still bring a shudder to some investors, wisely shy about the riotous debate the field of research sparked last year between fervent camps of various persuasions -- some concerned more with religious and ethical...

10 Biggest U.S. Gainers & Losers for the Week.
March 11, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Ista Pharma 86.27 Cubist Pharma 6.08 Cubist Pharma 41.87 Cephalon 6.02 IntraBiotics 38.71 Trimeris 5.39...

Public Financing of Biotechnology: February 2002.
March 11, 2002... Public Financing Of Biotechnology: February 2002 I. COMMENCED TRADING IN FEBRUARY INITIAL OFFERINGS Company Date Date Shares/ Shares (Symbol) (#) Filed Comm. Units (M) Price Out (M) ...

Other Financings of Public Biotechnology Companies: February 2002.
March 11, 2002... Other Financings of Public Biotechnology Companies: February 2002 TOTAL: $2,779.81M Company Type of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture Capital and Corporate Investments in Biotechnology Companies: February 2002.
March 11, 2002... Venture Capital And Corporate Investments In BiotechnologyCompanies: February 2002 1. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $241.6M Company Location Date Agilix Corp. New Haven, Conn. ...

BioWorld Stock Report for Public Biotechnology Companies.
March 11, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 3/1 3/8 WK YTD 3D Pharma DDDP 7.5 6.71 ...

Money Raised By Biotech In 2002.
March 11, 2002... Money Raised By Biotech In 2002: January-February Type of financing I ($M) F ($M) Total ($M) Public offerings 75.1 345.8 420.9 Private biotechs 341.0 241.6 582.6 Public/other 396.1 2,779.8 3,175.9...

I3C aims to make common (Protocol) sense of Genomics.
March 18, 2002... If the genomics revolution moved biotechnology out of test tubes and into computers, companies with their eyes on reasonably timed profits have been trying to move it back. But the best way to do that, say the organizers of the...

10 biggest U.S. gainers & losers for the week.
March 18, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Cepheid 50.68 Vertex Pharma 4.28 GalaGen 42.86 Scios 3.63 InKine Pharma 40.63 Genzyme 3.63 Repligen...

Clinical trial update: February 2002.
March 18, 2002... Clinical Trial Update: February 2002 CANCER Company (*) Product Description (Symbol) AltaRex Corp. OvaRex Oregovomab; a fully (Canada; TSE:AXO) foreign monoclonal ...

Non-U.S. clinical trials, regulatorym submissions, recommendations and approvals: February 2002.
March 18, 2002... Non-U.S. Clinical Trials,Regulatory Submissions, Recommendations And Approvals: February 2002 CANCER Company (*) Product Description (Symbol) Micromet AG MT103 Bispecific antibody (Germany) (*)...

FDA submissions, approvals and other actions: February 2002.
March 18, 2002... FDA Submissions, Approvals And Other Actions: February 2002 CANCER Company (*) Product Description (Symbol) Amgen Inc. Neulasta Pegfilgrastim; second (AMGN) ...

BioWorld stock report for public biotechnology companies.
March 18, 2002... Bioworld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 3/8 3/15 WK YTD 3D Pharma DDDP 6.71 6.3 ...

Waking up to Neurocrine Biosciences insomnia program.
March 25, 2002... With cancer, heart disease, AIDS, hepatitis C and inflammatory devils such as rheumatoid arthritis tormenting the world populace, hardly anybody's losing sleep over insomnia. But most of those afflicted with the condition would pay dearly...

10 biggest U.S. gainers & losers for the week.
March 25, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Collateral Thera 90.94 Scios 5.86 Dendrcon 28.72 Collateral Thera 5.00 Dyax 28.27 NeoPharm 3.77...

Collaborations between biotechnology companies and universities/non-profit institutions: Nov. 30, 2001 - March 20, 2002.
March 25, 2002... Collaborations Between Biotechnology Companies And Universities/Non-Profit Institutions: Nov. 30, 2001 - March 20, 2002 Company (*) University/ (Country; Symbol) Non-Profit 3rd Millennium Department...

BioWorld stock report for public biotechnology companies.
March 25, 2002... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close 3/15 3/22 WK YTD ...

London stock exchange.
March 25, 2002... LONDON STOCK EXCHANGE Company Symbol 3/15 3/22 %WK %YTD Volume Acambis ACM 372 340 -8.60 -3.00 4934 Antisoma ASM 24.5 21 -14.29 -40.85 429 British Biotech ...

Toronto stock exchange.
March 25, 2002... TORONTO STOCK EXCHANGE Company Symbol 3/15 3/22 %WK %YTD Volume Adherex AHX 0.47 0.46 -2.13 9.52 145 Angiotech Pharma ANP 73.3 74.69 1.90 -16.08 580 Anormad ...